Neuropeptides
Volume 44, Issue 5 , Pages 453-456 , October 2010

Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice

Received 10 March 2010 ,Accepted 10 May 2010.

References 

  1. Adler MW, Geller EB, Rosow C, Cochin J. The opioid system and temperature regulation. Ann. Rev. Pharmacol. Toxicol. 1988;28:429–449
  2. Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, Durkin MM, et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 2000;275:39324–39331
  3. Chen X, Herbert J. Regional changes in c-fos expression in the basal forebrain and brainstem during adaptation to repeated stress: correlations with cardiovascular, hypothermic and endocrine responses. Neuroscience. 1995;64(3):675–685
  4. Desprat C, Zajac J-M. Hypothermic effects of Neuropeptide FF analogues in mice. Pharmacol. Biochem. Behav. 1997;58:559–563
  5. Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 2000;275:25965–25971
  6. Fang Q, Wang YQ, He F, Guo J, Chen Q, Wang R. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist. Regul. Pept. 2008;147:45–51
  7. Gouardères C, Jhamandas K, Sutak M, Zajac J-M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 1996;117:493–501
  8. Gouardères C, Puget A, Zajac JM. Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: a comparative autoradiographic study. Synapse. 2004;51:249–269
  9. Gouarderes C, Tafani JA, Zajac JM. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord. Peptides. 1998;19:727–730
  10. Hinuma S, Shintani Y, Fukusumi S, Iijima N, Matsumoto Y, Hosoya M, et al. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat. Cell. Biol. 2000;2:703–708
  11. Kotani M, Mollereau C, Detheux M, Le Poul E, Brezillon S, Vakili J, et al. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 2001;133:138–144
  12. Mollereau C, Mazarguil H, Zajac JM, Roumy M. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol. Pharmacol. 2005;67:965–975
  13. Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, et al. Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur. J. Pharmacol. 2002;451:245–256
  14. Moulédous, L.F., B. Zajac J.-M., 2010. Modulation of basal and morphine-induced neuronal activity by a NPFF2 selective agonist measured by c-fos mapping of the mouse brain. Synapse., doi:10.1002/syn.20774.
  15. Panula P, Aarnisalo AA, Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 1996;48:461–487
  16. Quelven I, Roussin A, Zajac JM. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists. Eur. J. Pharmacol. 2005;508:107–114
  17. Rebeyrolles S, Zajac JM, Roumy M. Neuropeptide FF reverses the effect of mu-opioid on Ca2+ channels in rat spinal ganglion neurones. Neuroreport. 1996;7:2979–2981
  18. Romanovsky AA. Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R37–R46
  19. Roumy M, Lorenzo C, Mazeres S, Bouchet S, Zajac JM, Mollereau C. Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity. J. Biol. Chem. 2007;282:8332–8342
  20. Roumy M, Zajac J-M. Neuropeptide FF selectively attenuates the effects of nociceptin on acutely dissociated neurons of the rat dorsal raphe nucleus. Brain Res. 1999;845:208–214
  21. Roumy M, Zajac J-M. Neuropeptide FF, pain and analgesia. Eur. J. Pharmacol. 1998;345:1–11
  22. Roussin A, Serre F, Gouarderes C, Mazarguil H, Roumy M, Mollereau C, et al. Anti-analgesia of a selective NPFF2 agonist depends on opioid activity. Biochem. Biophys. Res. Commun. 2005;336:197–203
  23. Simonin F, Schmitt M, Laulin JP, Laboureyras E, Jhamandas JH, MacTavish D, et al. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc. Natl. Acad. Sci. USA. 2006;103:466–471
  24. Southey BR, Rodriguez-Zas SL, Sweedler JV. Prediction of neuropeptide prohormone cleavages with application to RFamides. Peptides. 2006;27:1087–1098
  25. Yang HY, Iadarola MJ. Modulatory roles of the NPFF system in pain mechanisms at the spinal level. Peptides. 2006;27:943–952
  26. Zajac JM, Latapie JP, Frances B. Opposing interplay between Neuropeptide FF and nitric oxide in antinociception and hypothermia. Peptides. 2000;21:1209–1213

PII: S0143-4179(10)00052-1

doi: 10.1016/j.npep.2010.05.003

Neuropeptides
Volume 44, Issue 5 , Pages 453-456 , October 2010

Article Tools

* Image Usage & Resolution